Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results - Martin, DF; Maguire, MG; Fine, SL; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Writing Committee (Ophthalmology, 2020)